Black Swift Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,280
Closed -$1.7M 133
2024
Q3
$1.7M Sell
14,280
-37,720
-73% -$5.03M 0.38% 53
2024
Q2
$7.42M Sell
52,000
-7,010
-12% -$929K 1.71% 8
2024
Q1
$7.58M Buy
59,010
+42,810
+264% +$5.1M 1.94% 9
2023
Q4
$1.68M Buy
+16,200
New +$1.6M 0.5% 45

Other funds holding NVO

Black Swift Group's NVO Position: Q4 2024 in Review

Black Swift Group sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 14,280 shares — an estimated $1.7M sold.

Black Swift Group first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $7.58M in Q1 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Black Swift Group reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Black Swift Group sold 14,280 Novo Nordisk shares in Q4 2024, an estimated $1.7M.
  • Black Swift Group first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • Black Swift Group's Novo Nordisk position peaked at $7.58M in Q1 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Black Swift Group's 13F filing for Q4 2024, filed 6 Feb 2025.